Our results showed positive correlations between PHD1 and PHD2 and all three studied HIF downstream targets, which further supports our results that decreased PHD1 and PHD2 are associated with the development of NSCLC. The gene discussed is EGLN2; the disease is non-small cell lung carcinoma.